EPISODE · Jan 31, 2025 · 15 MIN
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 5 Identifying CQAs and CPPs
from Cannabinoid and Psychedelic Pharmacology and Drug Development
This podcast episode explores Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs) in the manufacturing of botanical and psychedelic products. The discussion covers key aspects of product quality including potency, purity, safety, and stability. The episode delves into the complexities of extraction processes, including solvent choice and temperature control, while explaining how design space functions as a framework for ensuring consistent product quality through careful control of manufacturing parameters. The conversation also covers formulation challenges, packaging considerations, and the importance of proper storage and labeling in maintaining product integrity.
NOW PLAYING
30 Day FDA Drug Development in Cannabinoid and Psychedelic Spaces - Day 5 Identifying CQAs and CPPs
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.